Parkinson's disease and cancer: the unexplored connection.
Garber
Ken
K
D017668:Age of Onset; D018912:Arabs / Q000235:genetics; D001943:Breast Neoplasms / Q000150:complications; D019927:Cyclin E / Q000378:metabolism; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D007585:Jews / Q000235:genetics; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D008545:Melanoma / Q000150:complications; D009154:Mutation; D009369:Neoplasms / Q000150:complications* / Q000453:epidemiology / Q000235:genetics; D015513:Oncogene Proteins / Q000235:genetics*; D010300:Parkinson Disease / Q000150:complications* / Q000453:epidemiology / Q000235:genetics; D000071617:Protein Deglycase DJ-1; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D044767:Ubiquitin-Protein Ligases / Q000235:genetics*
D019927:Cyclin E; D047908:Intracellular Signaling Peptides and Proteins; D015513:Oncogene Proteins; D044767:Ubiquitin-Protein Ligases; C111567:parkin protein; C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases; C105131:PARK7 protein, human; D000071617:Protein Deglycase DJ-1